Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01716208 · OUTCOME

Overall Survival

Ofatumumab and Fresh Frozen Plasma in Patients With Chronic Lymphocytic Lymphoma · Source last updated 2021-05-11

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
Up to two years

What was measured

Count of participants known to be alive up to two years from the time from start of treatment.

Groups in this outcome

Ofatumumab + Fresh Frozen Plasma

Ofatumumab will be infused intravenously on day 1 (300 mg initial dose), followed one week later by 2000 mg weekly for 7 doses, followed 4 weeks later by 2000 mg every 4 weeks for 4 doses. Two units (approximately 200 or 250 ml) of FFP will be administered prior to ofatumumab(with the exception of the first dose). A unit of fresh frozen plasma is approximately 250ml (or half a pint). Ofatumumab + Fresh Frozen Plasma

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Ofatumumab + Fresh Frozen Plasma12

Reported measurements

Source class 1
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Ofatumumab + Fresh Frozen Plasma11Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        11
denoms
  1. counts
    1. group Id
      OG000
      value
      12
    units
    Participants
description
Count of participants known to be alive up to two years from the time from start of treatment.
groups
  1. description
    Ofatumumab will be infused intravenously on day 1 (300 mg initial dose), followed one week later by 2000 mg weekly for 7 doses, followed 4 weeks later by 2000 mg every 4 weeks for 4 doses. Two units (approximately 200 or 250 ml) of FFP will be administered prior to ofatumumab(with the exception of the first dose). A unit of fresh frozen plasma is approximately 250ml (or half a pint). Ofatumumab + Fresh Frozen Plasma
    id
    OG000
    title
    Ofatumumab + Fresh Frozen Plasma
param Type
COUNT_OF_PARTICIPANTS
reporting Status
POSTED
time Frame
Up to two years
title
Overall Survival
type
SECONDARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice